Salvage brentuximab vedotin prior to allogeneic hematopoietic cell transplantation in classical hodgkin lymphoma does not impact survival but reduces the incidence of chronic GVHD: a retrospective study of the EBMT Lymphoma Working Party.
Authors
Bazarbachi, ABoumendil, A
Finel, H
Mohty, M
Castagna, L
Peggs, K
Blaise, D
Afanasyev, B
Martin, J
Sierra, J
Bloor, Adrian
Martinez, C
Robinson, S
Craddock, C
Corradini, P
Montoto, S
Dreger, P
Sureda, A
Affiliation
Department of internal medicine, American University of Beirut, Faculty of Medicine, Beirut, LebanonIssue Date
2017